Aimmune Therapeutics Inc. (AIMT) shares are trading at lower $34.31 and the avg recommendation for the stock is Moderate Buy. while the current analyst price target stands at $32.77.
To add more color to this target, the company’s high over the last year is $37.00 and the low is $10.09. Over the last 52 weeks, AIMT is up 47.76% while the S&P 500 is up 13.33%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
AIMT Return on Equity (ROE) is -170.90%, and its Return on Assets is -92.70%. All told, it is clear that, AIMT needs to be on your watchlist.
FREE CONFIDENTIAL REPORT
3 Stocks Set To Soar By January 1st, 2021
You have Successfully Subscribed!
Find out when AIMT reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. AIMT has a short ratio of 8.61 and outstanding shares of 65.18M.
AIMT has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 1.53 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -4.49. Aimmune Therapeutics Inc. AIMT also noted assets of $365.29 million at the end of the last quarter. Investors should also keep an eye on sector updates as AIMT has historically followed its peers on positive news.
All told, Aimmune Therapeutics Inc. AIMT has strung together solid data and demonstrated underlying fundamentals. At its current valuation, AIMT represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
Aimmune Therapeutics Inc. AIMT is now commanding a market cap of 2.24B and a float of 50.98M. AIMT is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of AIMT stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in AIMT, either long or short, and we have not been compensated for this article.